logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Evofem Appoints Ivy Zhang As Chief Financial Officer and Secretary

Apr 14, 2023•over 2 years ago

Company

Evofem Biosciences

San DiegoBiotechnology

Description

Evofem Biosciences, Inc., , the maker of Phexxi® , today announced the appointment of Ivy Zhang as Chief Financial Officer and Secretary, effective April 13, 2023. Reporting to Chief Executive Officer Saundra Pelletier, Ms. Zhang will lead Evofem's finance organization and financial activities including financial planning and analysis, accounting, external audit, tax, controllership, and treasury functions.","Ms

Company Information

Company

Evofem Biosciences

Location

7770 Regents Road

San Diego, California, United States

About

Evofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health. In September 2020, Evofem launched Phexxi, the first and only hormone-free, on-demand, prescription birth control available in the U.S. that women use only when they have sex. In July 2024, Evofem acquired SOLOSEC, an FDA-approved single-dose oral antimicrobial agent for the treatment of two common sexual health infections: trichomoniasis and bacterial vaginosis.

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months